Galderma Group AG-Unspon ADRGALDY
13F holders, Q4 2025 (December 31)4holders +2
1new positions
0sold out
$41.44avg. 13F price*
At the end of Q4 2025, 4 institutions reported holding Galderma Group AG-Unspon ADR (GALDY) in their 13F filings, up 2 from Q3 2025. 1 opened new positions and 0 sold out. The largest holders were Rhumbline Advisers ($878K), PNC Financial Services Group, Inc. ($81K) and Salomon & Ludwin, LLC ($10K).
- Company
- Galderma Group AG-Unspon ADR
- CUSIP
- 36321W105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $81K |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 17,497 shares bought, net +17,497 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Rhumbline Advisers | 0.00% | Add +274.9% | 21,194 | $878K |
| PNC Financial Services Group, Inc. | 0.00% | New | 1,949 | $81K |
| Salomon & Ludwin, LLC | 0.00% | Add +3.1% | 236 | $10K |
| Signature Equity Partners, LLC | 0.00% | — | 70 | $3K |
"% of holder's portfolio" is GALDY's weight in each manager's 13F, not the share of Galderma Group AG-Unspon ADR the manager owns.